| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.052 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |